ISRG
Intuitive Surgical, Inc.
NasdaqGSUSDEQUITY
Healthcare
DELAYED
Neutral
+8/100
Last price
404.90
▼ 1.58 (0.39%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
409.86
Prev close
406.48
Day high
409.29
Day low
402.00
Volume
1.65M
Market cap
$142.99B
P/E (TTM)
46.63
52W range
328.57 – 603.88
Day trading desk
Gap from prior close
+0.83%
Prior close 406.48
VWAP
405.02
-0.03% from price
Relative volume
0.78×
Normal
Session range
1.99%
402.00 – 409.99
Position in range
36%
Mid range
ATR (14D)
11.16
2.76% of price
Prior day high
407.63
PDH
Prior day low
389.11
PDL
Bid / ask spread
—
Quote not published
Session volume
2.27M
Avg 2.91M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-1.80%
-3.7%
1M
+10.38%
+9.2%
3M
-2.49%
-7.0%
6M
-10.64%
-28.8%
YTD
-28.53%
-42.8%
1Y
-10.52%
-26.9%
3Y
+38.48%
-43.8%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on ISRG open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
-4.87K
Net selling
Buy transactions
13
14.98K shares
Sell transactions
18
19.85K shares
Net transactions
+31
Buys less sells
Sell : buy shares
1.3 : 1
Mixed
Insider-held shares
1.81M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Sep 15, 26 | WIDMAN FREDRIK Officer |
SELL | 1.09K | $407.76K | Direct |
| Sep 15, 26 | WIDMAN FREDRIK Officer |
CONVERSION | 1.09K | $102.93K | Direct |
| Sep 11, 26 | BROSIUS MARK PRESTON Officer |
SELL | 48 | $17.14K | Direct |
| Sep 9, 26 | BROSIUS MARK PRESTON Officer |
SELL | 69 | $24.67K | Direct |
| Aug 21, 26 | BROSIUS MARK PRESTON Officer |
SELL | 154 | $59.44K | Direct |
| Aug 19, 26 | BROSIUS MARK PRESTON Officer |
SELL | 231 | $90.78K | Direct |
| Aug 11, 26 | GUTHART GARY S Director |
SELL | 10.00K | $4.00M | Indirect |
| Aug 11, 26 | LADD AMY L Director |
SELL | 472 | $179.90K | Direct |
| Aug 10, 26 | LOEB GARY Officer |
SELL | 400 | $151.60K | Direct |
| Jul 31, 26 | BROSIUS MARK PRESTON Officer |
SELL | 56 | $19.54K | Direct |
| Jul 29, 26 | BROSIUS MARK PRESTON Officer |
SELL | 84 | $29.95K | Direct |
| Jul 10, 26 | ROSA DAVID J Chief Executive Officer |
— | 1.91K | — | Direct |
| Jun 12, 26 | BROSIUS MARK PRESTON Officer |
SELL | 48 | $19.83K | Direct |
| Jun 10, 26 | BROSIUS MARK PRESTON Officer |
SELL | 69 | $29.10K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BARRATT CRAIG H |
Director | — | Conversion of Exercise of derivative security |
CHARLTON HENRY L |
Officer | 11.61K | Conversion of Exercise of derivative security |
GUTHART GARY S |
Director | — | Sale |
JEDDI IMAN |
Officer | 33.11K | Sale |
JOHNSON AMAL M |
Director | 13.54K | Conversion of Exercise of derivative security |
MILLER BRIAN EDWARD |
Officer | 5.76K | Sale |
NACHTSHEIM JAMI DOVER K |
Director | 6.90K | Conversion of Exercise of derivative security |
ROSA DAVID J |
Chief Executive Officer | 246.86K | Conversion of Exercise of derivative security |
RUBASH MARK JEFFREY |
Director | 16.79K | Conversion of Exercise of derivative security |
SAMATH JAMIE E. |
Officer | 15.37K | Conversion of Exercise of derivative security |
Fundamentals
Market cap$142.99B
Enterprise value$137.91B
Revenue (TTM)$11.03B
Gross profit$7.36B
EBITDA$4.18B
Net income$3.14B
EPS (TTM)$8.68
Free cash flow$2.62B
Total cash$5.22B
Total debt$0
Book value / share$51.34
Shares outstanding353.28M
Float351.21M
Short % of float2.31%
Dividend yield0.00%
Beta (5Y)1.46
Valuation & profitability ratios
Trailing P/E46.63
Forward P/E33.46
PEG ratio1.89
Price / sales—
Price / book7.88
EV / revenue12.50
EV / EBITDA32.99
Gross margin66.68%
Operating margin33.60%
Profit margin28.45%
Return on equity17.42%
Return on assets10.51%
Debt / equity—
Current ratio4.96
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $10.06B | $8.35B | $7.12B | $6.22B | +20.5% |
| Operating revenue | $10.06B | $8.35B | $7.12B | $6.22B | +20.5% |
| Cost of revenue | $3.42B | $2.72B | $2.39B | $2.03B | +25.9% |
| Gross profit | $6.64B | $5.63B | $4.73B | $4.20B | +17.9% |
| Research & development | $1.31B | $1.15B | $998.80M | $879.00M | +14.5% |
| Selling, general & admin | $2.38B | $2.14B | $1.96B | $1.74B | +11.4% |
| Total operating expense | $3.70B | $3.29B | $2.96B | $2.62B | +12.5% |
| Operating income | $2.95B | $2.35B | $1.77B | $1.58B | +25.4% |
| Net interest income | $365.90M | $324.90M | $192.10M | $29.70M | +12.6% |
| Pre-tax income | $3.31B | $2.67B | $1.96B | $1.61B | +23.8% |
| Tax provision | $434.80M | $336.30M | $141.60M | $262.40M | +29.3% |
| Net income to common | $2.86B | $2.32B | $1.80B | $1.32B | +23.0% |
| Basic EPS | 8.00 | 6.54 | 5.12 | 3.72 | +22.3% |
| Diluted EPS | 7.87 | 6.42 | 5.03 | 3.65 | +22.6% |
| EBIT | $2.95B | $2.35B | $1.77B | $1.58B | +25.4% |
| EBITDA | $3.62B | $2.85B | $2.22B | $1.94B | +27.2% |
| Basic shares | 356.90M | 355.20M | 351.20M | 355.70M | +0.5% |
| Diluted shares | 362.70M | 362.00M | 357.40M | 362.00M | +0.2% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $3.37B | $2.03B | $2.75B | $1.58B | — | +66.1% |
| Cash & short-term investments | $5.93B | $4.01B | $5.22B | $4.12B | — | +47.9% |
| Accounts receivable | $1.53B | $1.23B | $1.13B | $942.10M | — | +24.6% |
| Inventory | $1.84B | $1.49B | $1.22B | $893.20M | — | +23.7% |
| Total current assets | $9.78B | $7.11B | $7.89B | $6.25B | — | +37.5% |
| Property, plant & equipment | $5.34B | $4.65B | $3.54B | $2.37B | — | +15.0% |
| Goodwill & intangibles | $381.40M | $370.50M | $387.80M | $398.30M | — | +2.9% |
| Total assets | $20.46B | $18.74B | $15.44B | $12.97B | — | +9.2% |
| Total current liabilities | $2.01B | $1.75B | $1.66B | $1.42B | — | +14.9% |
| Total debt | — | — | — | — | $87.00M | — |
| Total liabilities | $2.52B | $2.21B | $2.04B | $1.86B | — | +13.7% |
| Retained earnings | $7.01B | $6.80B | $4.74B | $3.50B | — | +3.1% |
| Shareholder equity | $17.82B | $16.43B | $13.31B | $11.04B | — | +8.5% |
| Working capital | $7.77B | $5.37B | $6.23B | $4.83B | — | +44.9% |
| Net tangible assets | $17.44B | $16.06B | $12.92B | $10.64B | — | +8.6% |
| Shares issued | 355.10M | 356.60M | 352.30M | 350.00M | — | -0.4% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $2.88B | $2.34B | $1.82B | $1.34B | +23.1% |
| Depreciation & amortisation | $677.10M | $499.70M | $454.80M | $365.80M | +35.5% |
| Stock-based compensation | $788.20M | $676.80M | $592.80M | $513.20M | +16.5% |
| Change in working capital | -$1.27B | -$919.30M | -$777.60M | -$619.10M | -38.4% |
| Operating cash flow | $3.03B | $2.42B | $1.81B | $1.49B | +25.5% |
| Capital expenditure | -$539.80M | -$1.11B | -$1.06B | -$532.40M | +51.4% |
| Investing cash flow | $665.80M | -$3.27B | -$360.10M | $1.37B | +120.3% |
| Share buybacks | -$2.30B | $0 | -$416.30M | -$2.61B | — |
| Financing cash flow | -$2.36B | $150.90M | -$287.60M | -$2.57B | -1,666.7% |
| Free cash flow | $2.49B | $1.30B | $749.60M | $958.40M | +91.0% |
| End cash position | $3.41B | $2.06B | $2.77B | $1.60B | +65.2% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $2.89B | $2.77B | $2.87B | $2.51B | $2.44B | +4.4% |
| Operating revenue | $2.89B | $2.77B | $2.87B | $2.51B | $2.44B | +4.4% |
| Cost of revenue | $931.90M | $940.30M | $961.90M | $842.70M | $822.10M | -0.9% |
| Gross profit | $1.96B | $1.83B | $1.90B | $1.66B | $1.62B | +7.1% |
| Research & development | $370.60M | $361.90M | $352.90M | $329.40M | $313.30M | +2.4% |
| Selling, general & admin | $617.90M | $613.30M | $687.10M | $573.30M | $561.20M | +0.8% |
| Total operating expense | $988.50M | $975.20M | $1.04B | $902.70M | $874.50M | +1.4% |
| Operating income | $971.90M | $855.30M | $864.30M | $759.70M | $743.40M | +13.6% |
| Net interest income | $82.70M | $85.10M | $91.30M | $95.50M | $88.70M | -2.8% |
| Pre-tax income | $1.05B | $940.40M | $955.60M | $855.20M | $832.10M | +12.1% |
| Tax provision | $231.40M | $114.40M | $156.10M | $146.00M | $167.90M | +102.3% |
| Net income | $818.10M | $821.50M | $794.80M | $704.40M | $658.40M | -0.4% |
| Net income to common | $818.10M | $821.50M | $794.80M | $704.40M | $658.40M | -0.4% |
| Basic EPS | 2.31 | 2.31 | 2.24 | 1.98 | 1.84 | 0.0% |
| Diluted EPS | 2.29 | 2.28 | 2.21 | 1.95 | 1.81 | +0.4% |
| EBIT | $971.90M | $855.30M | $864.30M | $759.70M | $743.40M | +13.6% |
| EBITDA | $1.20B | $1.06B | $1.09B | $901.90M | $907.80M | +14.0% |
| Basic shares | 354.10M | 354.90M | 354.90M | 356.60M | 358.50M | -0.2% |
| Diluted shares | 357.30M | 359.80M | 360.40M | 361.80M | 364.10M | -0.7% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $2.76B | $2.01B | $3.37B | $2.81B | $3.40B | +37.6% |
| Cash & short-term investments | $5.22B | $4.52B | $5.93B | $4.91B | $5.33B | +15.5% |
| Accounts receivable | $1.43B | $1.39B | $1.53B | $1.12B | $1.13B | +3.0% |
| Inventory | $2.03B | $1.95B | $1.84B | $1.78B | $1.67B | +4.3% |
| Total current assets | $9.54B | $8.81B | $9.78B | $8.53B | $8.75B | +8.3% |
| Property, plant & equipment | $5.55B | $5.45B | $5.34B | $5.15B | $4.99B | +1.9% |
| Goodwill & intangibles | $778.60M | $780.70M | $381.40M | $362.60M | $366.60M | -0.3% |
| Total assets | $20.88B | $20.11B | $20.46B | $19.35B | $20.16B | +3.8% |
| Total current liabilities | $1.92B | $1.91B | $2.01B | $1.80B | $1.69B | +0.6% |
| Total liabilities | $2.58B | $2.51B | $2.52B | $2.31B | $2.21B | +2.6% |
| Retained earnings | $6.84B | $6.40B | $7.01B | $6.42B | $7.61B | +6.9% |
| Shareholder equity | $18.17B | $17.47B | $17.82B | $16.93B | $17.85B | +4.0% |
| Working capital | $7.62B | $6.90B | $7.77B | $6.72B | $7.05B | +10.5% |
| Net tangible assets | $17.39B | $16.69B | $17.44B | $16.57B | $17.48B | +4.2% |
| Shares issued | 353.90M | 354.40M | 355.10M | 354.90M | 358.42M | -0.1% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $823.20M | $826.00M | $799.50M | $709.20M | $664.20M | -0.3% |
| Depreciation & amortisation | $231.10M | $200.00M | $220.90M | $142.20M | $164.40M | +15.6% |
| Stock-based compensation | $209.90M | $209.50M | $203.30M | $203.50M | $196.20M | +0.2% |
| Change in working capital | -$225.40M | -$644.80M | -$248.40M | -$314.40M | -$270.20M | +65.0% |
| Operating cash flow | $1.06B | $911.90M | $892.50M | $841.00M | $715.40M | +16.4% |
| Capital expenditure | -$112.60M | -$103.30M | -$162.50M | -$105.40M | -$155.30M | -9.0% |
| Investing cash flow | -$26.60M | -$914.50M | -$209.40M | $401.00M | $260.70M | +97.1% |
| Share buybacks | -$320.30M | -$1.12B | -$201.00M | -$1.91B | -$181.00M | +71.5% |
| Financing cash flow | -$287.90M | -$1.35B | -$137.50M | -$1.84B | -$147.80M | +78.7% |
| Free cash flow | $948.40M | $808.60M | $730.00M | $735.60M | $560.10M | +17.3% |
| End cash position | $2.81B | $2.05B | $3.41B | $2.85B | $3.45B | +36.7% |
Options analytics
Put / call volume
0.10
Call-heavy session
Put / call open interest
0.70
Positioning, not flow
Max pain
390.00
-3.6% from spot
ATM implied vol
45.2%
Nearest strike to spot
Skew (10% OTM)
+4.9%
Puts bid over calls
Call volume
1.32K
Contracts, this expiry
Put volume
128
Contracts, this expiry
Heaviest call OI
420.00
258 contracts
Heaviest put OI
370.00
376 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 2.50 | 2.80 | +11.9% |
| Mar 2026 | 2.11 | 2.50 | +18.7% |
| Dec 2025 | 2.27 | 2.53 | +11.6% |
| Sep 2025 | 1.99 | 2.40 | +20.7% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 2.64 | 23 | $2.91B | +16.0% |
| Next quarter | 2.84 | 23 | $3.21B | +12.1% |
| Current year | 10.78 | 27 | $11.76B | +16.8% |
| Next year | 12.10 | 27 | $13.26B | +12.8% |
Analyst targets & ownership
Mean target$477.21
High target$685.00
Low target$324.00
Implied upside17.86%
Analyst count29
ConsensusBUY
Strong buy / Buy7 / 17
Hold7
Sell / Strong sell1 / 0
Held by insiders0.51%
Held by institutions89.46%
Institutions holding3.13K
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
404.10
+0.20% from price
SMA 20
392.09
+3.23% from price
SMA 50
382.38
+5.85% from price
SMA 100
393.98
+2.77% from price
SMA 200
445.71
-9.19% from price
EMA 12
400.08
+1.20% from price
EMA 26
392.62
+3.13% from price
EMA 50
389.89
+3.85% from price
RSI (14)
58.0
Neutral
MACD (12,26,9)
7.46
Hist 0.54
ATR (14)
11.16
2.76% of price
Realised vol 30D
27.5%
Annualised
Bollinger upper
425.76
20, 2σ
Bollinger lower
358.43
20, 2σ
50 / 200 cross
Death
382.38 vs 445.71
Trend bias
Below 200
-9.19%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.92
Less volatile than market
Correlation to SPY
0.33
Loosely linked
Realised vol 30D
27.5%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-44.0%
Peak to trough
Max drawdown 5Y
-49.9%
Peak to trough
ATR 14
11.16
2.76% of price
Beta (reported)
1.46
5Y monthly, from filing
Short interest
Shares short
8.12M
Prior 7.07M
Change vs prior
+14.8%
Shorts adding
% of float
2.31%
Normal
% of shares out
2.30%
Against total outstanding
Days to cover
3.6
Liquid
Float
351.21M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 8, 26 | BTIG | MAINTAINED | Buy | Buy |
| Aug 12, 26 | Oppenheimer | UPGRADE | Perform | Outperform |
| Jul 30, 26 | HSBC | DOWNGRADE | Buy | Hold |
| Jul 17, 26 | Raymond James | MAINTAINED | Outperform | Outperform |
| Jul 17, 26 | Piper Sandler | MAINTAINED | Overweight | Overweight |
| Jul 17, 26 | JP Morgan | MAINTAINED | Overweight | Overweight |
| Jul 17, 26 | Mizuho | MAINTAINED | Neutral | Neutral |
| Jul 17, 26 | Wells Fargo | MAINTAINED | Overweight | Overweight |
| Jul 17, 26 | TD Cowen | MAINTAINED | Buy | Buy |
| Jul 17, 26 | Evercore ISI Group | MAINTAINED | In-Line | In-Line |
| Jul 17, 26 | RBC Capital | MAINTAINED | Outperform | Outperform |
| Jul 17, 26 | Stifel | MAINTAINED | Buy | Buy |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split3:1
Split dateOct 5, 2021
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-07-27
Offering Registrations
S-8 · 2026-07-21
Corporate Changes & Voting Matters
8-K · 2026-07-16
Corporate Changes & Voting Matters
8-K · 2026-05-28
Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)
SD · 2026-05-21
Corporate Changes & Voting Matters
8-K · 2026-05-04
Periodic Financial Reports
10-Q · 2026-04-22
Corporate Changes & Voting Matters
8-K · 2026-04-21
Headlines
What Could Lift ISRG Stock?
Trefis · 14h ago
If The MiniMed Split-Off Stalls, What Happens To Your Medtronic Stock?
Trefis · 16h ago
Zacks Industry Outlook Globus Medical, Intuitive Surgical and Thermo Fisher Scientific
Zacks · 23h ago
Inspire Medical Gains New CPT Codes for Hypoglossal Nerve Stimulation
Zacks · 2d ago
2 Beaten-Down Stocks Worth Buying and Holding for the Next Decade
Motley Fool · 2d ago
3 Medical Instruments Stocks Using GenAI to Navigate Industry Woes
Zacks · 2d ago
Evercore ISI Adjusts Intuitive Surgical Price Target to $400 From $375, Maintains In Line Rating
MT Newswires · 2d ago
Intuitive Surgical (ISRG): Is Its Robotic-Surgery Moat Still Untouchable?
Insider Monkey · 4d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.